{
  "spec_version": "4",
  "endpoint": "financials-segment",
  "stock_code": "4403",
  "company_name": "日油",
  "content_lang": "ja",
  "meta_lang": "en",
  "canonical_url": "https://the-shashi.com/tse/4403/current/#revenue-mix",
  "api_url": "/api/4403/financials/segment.json",
  "updated": "2026-09-18",
  "license": "© 2026 Yutaka Sugiura. All rights reserved.",
  "attribution": "The社史 (the-shashi.com) — https://the-shashi.com/tse/4403/current/#revenue-mix",
  "source": {
    "segment": {
      "primary": [
        "有価証券報告書（セグメント情報）"
      ],
      "extraction": "EDINET の XBRL から機械抽出",
      "caveat": "セグメント区分は各期の開示区分をそのまま採録しており、期をまたいだ区分の連続性は保証しない"
    },
    "region": {
      "primary": [
        "有価証券報告書（所在地別・海外売上高）"
      ],
      "extraction": "EDINET の XBRL から機械抽出",
      "caveat": "地域区分は各期の開示区分をそのまま採録している"
    },
    "revenue_mix": {
      "primary": [
        "有価証券報告書（生産・受注及び販売の状況）"
      ],
      "extraction": "EDINET の XBRL と有価証券報告書の記述から機械抽出",
      "caveat": "軸（axis）は品目・用途・主要顧客など開示に依り、社ごと期ごとに揃わない。どの開示から起こした行かは source_tag 列を参照"
    }
  },
  "html_url": "https://the-shashi.com/tse/4403/current/#revenue-mix",
  "segment": [
    {
      "FY": "FY16",
      "period": "2017/3",
      "unit": "百万円",
      "accounting_standard": "JGAAP",
      "consolidation": "連結",
      "segment": "ライフサイエンス事業",
      "sales": 26494,
      "profit": 6208,
      "assets": 21394
    },
    {
      "FY": "FY16",
      "period": "2017/3",
      "unit": "百万円",
      "accounting_standard": "JGAAP",
      "consolidation": "連結",
      "segment": "化薬事業",
      "sales": 35444,
      "profit": 2386,
      "assets": 55791
    },
    {
      "FY": "FY16",
      "period": "2017/3",
      "unit": "百万円",
      "accounting_standard": "JGAAP",
      "consolidation": "連結",
      "segment": "機能化学品事業",
      "sales": 110750,
      "profit": 16909,
      "assets": 78599
    },
    {
      "FY": "FY17",
      "period": "2018/3",
      "unit": "百万円",
      "accounting_standard": "JGAAP",
      "consolidation": "連結",
      "segment": "ライフサイエンス事業",
      "sales": 27424,
      "profit": 7216,
      "assets": 22558
    },
    {
      "FY": "FY17",
      "period": "2018/3",
      "unit": "百万円",
      "accounting_standard": "JGAAP",
      "consolidation": "連結",
      "segment": "化薬事業",
      "sales": 30301,
      "profit": 1057,
      "assets": 55264
    },
    {
      "FY": "FY17",
      "period": "2018/3",
      "unit": "百万円",
      "accounting_standard": "JGAAP",
      "consolidation": "連結",
      "segment": "機能化学品事業",
      "sales": 120636,
      "profit": 18785,
      "assets": 88114
    },
    {
      "FY": "FY18",
      "period": "2019/3",
      "unit": "百万円",
      "accounting_standard": "JGAAP",
      "consolidation": "連結",
      "segment": "ライフサイエンス事業",
      "sales": 27814,
      "profit": 7388,
      "assets": 22999
    },
    {
      "FY": "FY18",
      "period": "2019/3",
      "unit": "百万円",
      "accounting_standard": "JGAAP",
      "consolidation": "連結",
      "segment": "化薬事業",
      "sales": 32202,
      "profit": 1967,
      "assets": 58809
    },
    {
      "FY": "FY18",
      "period": "2019/3",
      "unit": "百万円",
      "accounting_standard": "JGAAP",
      "consolidation": "連結",
      "segment": "機能化学品事業",
      "sales": 127512,
      "profit": 20297,
      "assets": 95221
    },
    {
      "FY": "FY19",
      "period": "2020/3",
      "unit": "百万円",
      "accounting_standard": "JGAAP",
      "consolidation": "連結",
      "segment": "ライフサイエンス事業",
      "sales": 30369,
      "profit": 8456,
      "assets": 21907
    },
    {
      "FY": "FY19",
      "period": "2020/3",
      "unit": "百万円",
      "accounting_standard": "JGAAP",
      "consolidation": "連結",
      "segment": "化薬事業",
      "sales": 31838,
      "profit": 1916,
      "assets": 58425
    },
    {
      "FY": "FY19",
      "period": "2020/3",
      "unit": "百万円",
      "accounting_standard": "JGAAP",
      "consolidation": "連結",
      "segment": "機能化学品事業",
      "sales": 117270,
      "profit": 17562,
      "assets": 91099
    },
    {
      "FY": "FY20",
      "period": "2021/3",
      "unit": "百万円",
      "accounting_standard": "JGAAP",
      "consolidation": "連結",
      "segment": "ライフサイエンス事業",
      "sales": 31232,
      "profit": 10310,
      "assets": 24353
    },
    {
      "FY": "FY20",
      "period": "2021/3",
      "unit": "百万円",
      "accounting_standard": "JGAAP",
      "consolidation": "連結",
      "segment": "化薬事業",
      "sales": 30078,
      "profit": 2036,
      "assets": 58313
    },
    {
      "FY": "FY20",
      "period": "2021/3",
      "unit": "百万円",
      "accounting_standard": "JGAAP",
      "consolidation": "連結",
      "segment": "機能化学品事業",
      "sales": 109822,
      "profit": 15655,
      "assets": 95572
    },
    {
      "FY": "FY21",
      "period": "2022/3",
      "unit": "百万円",
      "accounting_standard": "JGAAP",
      "consolidation": "連結",
      "segment": "ライフサイエンス事業",
      "sales": 33745,
      "profit": 14109,
      "assets": 28584
    },
    {
      "FY": "FY21",
      "period": "2022/3",
      "unit": "百万円",
      "accounting_standard": "JGAAP",
      "consolidation": "連結",
      "segment": "化薬事業",
      "sales": 30012,
      "profit": 1764,
      "assets": 57199
    },
    {
      "FY": "FY21",
      "period": "2022/3",
      "unit": "百万円",
      "accounting_standard": "JGAAP",
      "consolidation": "連結",
      "segment": "機能化学品事業",
      "sales": 128416,
      "profit": 21460,
      "assets": 110438
    },
    {
      "FY": "FY22",
      "period": "2023/3",
      "unit": "百万円",
      "accounting_standard": "JGAAP",
      "consolidation": "連結",
      "segment": "化薬事業",
      "sales": 29871,
      "profit": 1751,
      "assets": 58582
    },
    {
      "FY": "FY22",
      "period": "2023/3",
      "unit": "百万円",
      "accounting_standard": "JGAAP",
      "consolidation": "連結",
      "segment": "医薬・医療・健康事業",
      "sales": 51363,
      "profit": 18215,
      "assets": 37747
    },
    {
      "FY": "FY22",
      "period": "2023/3",
      "unit": "百万円",
      "accounting_standard": "JGAAP",
      "consolidation": "連結",
      "segment": "機能化学品事業",
      "sales": 135965,
      "profit": 22689,
      "assets": 118831
    },
    {
      "FY": "FY23",
      "period": "2024/3",
      "unit": "百万円",
      "accounting_standard": "JGAAP",
      "consolidation": "連結",
      "segment": "化薬事業",
      "sales": 34138,
      "profit": 2628,
      "assets": 67656
    },
    {
      "FY": "FY23",
      "period": "2024/3",
      "unit": "百万円",
      "accounting_standard": "JGAAP",
      "consolidation": "連結",
      "segment": "医薬・医療・健康事業",
      "sales": 53998,
      "profit": 20558,
      "assets": 47125
    },
    {
      "FY": "FY23",
      "period": "2024/3",
      "unit": "百万円",
      "accounting_standard": "JGAAP",
      "consolidation": "連結",
      "segment": "機能化学品事業",
      "sales": 133556,
      "profit": 21972,
      "assets": 127759
    },
    {
      "FY": "FY24",
      "period": "2025/3",
      "unit": "百万円",
      "accounting_standard": "JGAAP",
      "consolidation": "連結",
      "segment": "化薬事業",
      "sales": 38775,
      "profit": 3130,
      "assets": 77144
    },
    {
      "FY": "FY24",
      "period": "2025/3",
      "unit": "百万円",
      "accounting_standard": "JGAAP",
      "consolidation": "連結",
      "segment": "医薬・医療・健康事業",
      "sales": 48033,
      "profit": 15697,
      "assets": 54911
    },
    {
      "FY": "FY24",
      "period": "2025/3",
      "unit": "百万円",
      "accounting_standard": "JGAAP",
      "consolidation": "連結",
      "segment": "機能化学品事業",
      "sales": 150915,
      "profit": 29797,
      "assets": 133322
    },
    {
      "FY": "FY25",
      "period": "2026/3",
      "unit": "百万円",
      "accounting_standard": "JGAAP",
      "consolidation": "連結",
      "segment": "化薬事業",
      "sales": 61675,
      "profit": 7979,
      "assets": 99956
    },
    {
      "FY": "FY25",
      "period": "2026/3",
      "unit": "百万円",
      "accounting_standard": "JGAAP",
      "consolidation": "連結",
      "segment": "医薬・医療・健康事業",
      "sales": 49931,
      "profit": 15816,
      "assets": 52974
    },
    {
      "FY": "FY25",
      "period": "2026/3",
      "unit": "百万円",
      "accounting_standard": "JGAAP",
      "consolidation": "連結",
      "segment": "機能化学品事業",
      "sales": 145751,
      "profit": 26846,
      "assets": 141835
    }
  ],
  "region": [
    {
      "FY": "FY16",
      "period": "2017/3",
      "unit": "百万円",
      "accounting_standard": "JGAAP",
      "consolidation": "連結",
      "region": "その他",
      "sales": 18857
    },
    {
      "FY": "FY16",
      "period": "2017/3",
      "unit": "百万円",
      "accounting_standard": "JGAAP",
      "consolidation": "連結",
      "region": "アジア",
      "sales": 25680
    },
    {
      "FY": "FY16",
      "period": "2017/3",
      "unit": "百万円",
      "accounting_standard": "JGAAP",
      "consolidation": "連結",
      "region": "日本",
      "sales": 129519
    },
    {
      "FY": "FY17",
      "period": "2018/3",
      "unit": "百万円",
      "accounting_standard": "JGAAP",
      "consolidation": "連結",
      "region": "その他",
      "sales": 20213
    },
    {
      "FY": "FY17",
      "period": "2018/3",
      "unit": "百万円",
      "accounting_standard": "JGAAP",
      "consolidation": "連結",
      "region": "アジア",
      "sales": 29386
    },
    {
      "FY": "FY17",
      "period": "2018/3",
      "unit": "百万円",
      "accounting_standard": "JGAAP",
      "consolidation": "連結",
      "region": "日本",
      "sales": 130335
    },
    {
      "FY": "FY18",
      "period": "2019/3",
      "unit": "百万円",
      "accounting_standard": "JGAAP",
      "consolidation": "連結",
      "region": "その他",
      "sales": 20940
    },
    {
      "FY": "FY18",
      "period": "2019/3",
      "unit": "百万円",
      "accounting_standard": "JGAAP",
      "consolidation": "連結",
      "region": "アジア",
      "sales": 34686
    },
    {
      "FY": "FY18",
      "period": "2019/3",
      "unit": "百万円",
      "accounting_standard": "JGAAP",
      "consolidation": "連結",
      "region": "日本",
      "sales": 133525
    },
    {
      "FY": "FY19",
      "period": "2020/3",
      "unit": "百万円",
      "accounting_standard": "JGAAP",
      "consolidation": "連結",
      "region": "その他",
      "sales": 21126
    },
    {
      "FY": "FY19",
      "period": "2020/3",
      "unit": "百万円",
      "accounting_standard": "JGAAP",
      "consolidation": "連結",
      "region": "アジア",
      "sales": 30676
    },
    {
      "FY": "FY19",
      "period": "2020/3",
      "unit": "百万円",
      "accounting_standard": "JGAAP",
      "consolidation": "連結",
      "region": "日本",
      "sales": 129115
    },
    {
      "FY": "FY20",
      "period": "2021/3",
      "unit": "百万円",
      "accounting_standard": "JGAAP",
      "consolidation": "連結",
      "region": "その他",
      "sales": 20749
    },
    {
      "FY": "FY20",
      "period": "2021/3",
      "unit": "百万円",
      "accounting_standard": "JGAAP",
      "consolidation": "連結",
      "region": "アジア",
      "sales": 29428
    },
    {
      "FY": "FY20",
      "period": "2021/3",
      "unit": "百万円",
      "accounting_standard": "JGAAP",
      "consolidation": "連結",
      "region": "日本",
      "sales": 122467
    },
    {
      "FY": "FY21",
      "period": "2022/3",
      "unit": "百万円",
      "accounting_standard": "JGAAP",
      "consolidation": "連結",
      "region": "その他",
      "sales": 29717
    },
    {
      "FY": "FY21",
      "period": "2022/3",
      "unit": "百万円",
      "accounting_standard": "JGAAP",
      "consolidation": "連結",
      "region": "アジア",
      "sales": 33404
    },
    {
      "FY": "FY21",
      "period": "2022/3",
      "unit": "百万円",
      "accounting_standard": "JGAAP",
      "consolidation": "連結",
      "region": "日本",
      "sales": 129521
    },
    {
      "FY": "FY22",
      "period": "2023/3",
      "unit": "百万円",
      "accounting_standard": "JGAAP",
      "consolidation": "連結",
      "region": "その他",
      "sales": 35199
    },
    {
      "FY": "FY22",
      "period": "2023/3",
      "unit": "百万円",
      "accounting_standard": "JGAAP",
      "consolidation": "連結",
      "region": "アジア",
      "sales": 38130
    },
    {
      "FY": "FY22",
      "period": "2023/3",
      "unit": "百万円",
      "accounting_standard": "JGAAP",
      "consolidation": "連結",
      "region": "日本",
      "sales": 144380
    },
    {
      "FY": "FY23",
      "period": "2024/3",
      "unit": "百万円",
      "accounting_standard": "JGAAP",
      "consolidation": "連結",
      "region": "その他",
      "sales": 16373
    },
    {
      "FY": "FY23",
      "period": "2024/3",
      "unit": "百万円",
      "accounting_standard": "JGAAP",
      "consolidation": "連結",
      "region": "アジア",
      "sales": 35828
    },
    {
      "FY": "FY23",
      "period": "2024/3",
      "unit": "百万円",
      "accounting_standard": "JGAAP",
      "consolidation": "連結",
      "region": "日本",
      "sales": 147847
    },
    {
      "FY": "FY23",
      "period": "2024/3",
      "unit": "百万円",
      "accounting_standard": "JGAAP",
      "consolidation": "連結",
      "region": "欧州",
      "sales": 22203
    },
    {
      "FY": "FY24",
      "period": "2025/3",
      "unit": "百万円",
      "accounting_standard": "JGAAP",
      "consolidation": "連結",
      "region": "その他",
      "sales": 14393
    },
    {
      "FY": "FY24",
      "period": "2025/3",
      "unit": "百万円",
      "accounting_standard": "JGAAP",
      "consolidation": "連結",
      "region": "アジア",
      "sales": 37523
    },
    {
      "FY": "FY24",
      "period": "2025/3",
      "unit": "百万円",
      "accounting_standard": "JGAAP",
      "consolidation": "連結",
      "region": "日本",
      "sales": 165908
    },
    {
      "FY": "FY24",
      "period": "2025/3",
      "unit": "百万円",
      "accounting_standard": "JGAAP",
      "consolidation": "連結",
      "region": "欧州",
      "sales": 20484
    },
    {
      "FY": "FY25",
      "period": "2026/3",
      "unit": "百万円",
      "accounting_standard": "JGAAP",
      "consolidation": "連結",
      "region": "その他",
      "sales": 17314
    },
    {
      "FY": "FY25",
      "period": "2026/3",
      "unit": "百万円",
      "accounting_standard": "JGAAP",
      "consolidation": "連結",
      "region": "アジア",
      "sales": 37168
    },
    {
      "FY": "FY25",
      "period": "2026/3",
      "unit": "百万円",
      "accounting_standard": "JGAAP",
      "consolidation": "連結",
      "region": "日本",
      "sales": 186271
    },
    {
      "FY": "FY25",
      "period": "2026/3",
      "unit": "百万円",
      "accounting_standard": "JGAAP",
      "consolidation": "連結",
      "region": "欧州",
      "sales": 17212
    }
  ],
  "revenue_mix": [
    {
      "FY": "FY15",
      "period": "2016/3",
      "unit": "百万円",
      "accounting_standard": "JGAAP",
      "consolidation": "連結",
      "axis": "事業",
      "category": "機能化学品事業",
      "sales": 106319,
      "share_pct": null,
      "source_tag": "production_sales"
    },
    {
      "FY": "FY15",
      "period": "2016/3",
      "unit": "百万円",
      "accounting_standard": "JGAAP",
      "consolidation": "連結",
      "axis": "事業",
      "category": "ライフサイエンス事業",
      "sales": 26775,
      "share_pct": null,
      "source_tag": "production_sales"
    },
    {
      "FY": "FY15",
      "period": "2016/3",
      "unit": "百万円",
      "accounting_standard": "JGAAP",
      "consolidation": "連結",
      "axis": "事業",
      "category": "化薬事業",
      "sales": 35971,
      "share_pct": null,
      "source_tag": "production_sales"
    },
    {
      "FY": "FY15",
      "period": "2016/3",
      "unit": "百万円",
      "accounting_standard": "JGAAP",
      "consolidation": "連結",
      "axis": "事業",
      "category": "その他の事業",
      "sales": 1394,
      "share_pct": null,
      "source_tag": "production_sales"
    },
    {
      "FY": "FY16",
      "period": "2017/3",
      "unit": "百万円",
      "accounting_standard": "JGAAP",
      "consolidation": "連結",
      "axis": "事業",
      "category": "機能化学品事業",
      "sales": 110750,
      "share_pct": null,
      "source_tag": "production_sales"
    },
    {
      "FY": "FY16",
      "period": "2017/3",
      "unit": "百万円",
      "accounting_standard": "JGAAP",
      "consolidation": "連結",
      "axis": "事業",
      "category": "ライフサイエンス事業",
      "sales": 26494,
      "share_pct": null,
      "source_tag": "production_sales"
    },
    {
      "FY": "FY16",
      "period": "2017/3",
      "unit": "百万円",
      "accounting_standard": "JGAAP",
      "consolidation": "連結",
      "axis": "事業",
      "category": "化薬事業",
      "sales": 35444,
      "share_pct": null,
      "source_tag": "production_sales"
    },
    {
      "FY": "FY16",
      "period": "2017/3",
      "unit": "百万円",
      "accounting_standard": "JGAAP",
      "consolidation": "連結",
      "axis": "事業",
      "category": "その他の事業",
      "sales": 1367,
      "share_pct": null,
      "source_tag": "production_sales"
    },
    {
      "FY": "FY24",
      "period": "2025/3",
      "unit": "百万円",
      "accounting_standard": "JGAAP",
      "consolidation": "連結",
      "axis": "主要顧客",
      "category": "㈱良品計画",
      "sales": 32237,
      "share_pct": null,
      "source_tag": "major_customer"
    },
    {
      "FY": "FY25",
      "period": "2026/3",
      "unit": "百万円",
      "accounting_standard": "JGAAP",
      "consolidation": "連結",
      "axis": "主要顧客",
      "category": "㈱良品計画",
      "sales": 29475,
      "share_pct": null,
      "source_tag": "major_customer"
    }
  ]
}